LSL Pharma Group Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Dec '24 Dec 20, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 30, 2022	Dec '21 Dec 30, 2021	Dec '20 Dec 30, 2020	Oct '20 Oct 2, 2020
Market Capitalization	39	40	-	-	-	-
Enterprise Value	53	54	-	-	-	-
Last Close Price	0.34	0.48	-	-	-	-
PS Ratio	2.05	3.99	-	-	-	-
PB Ratio	1.90	4.62	-	-	-	-
EV/Sales Ratio	3.32	5.37	-	-	-	-
Debt / Equity Ratio	0.69	1.88	2.84	1.15	1.02	1.41
Debt / EBITDA Ratio	21.54	-	-	47.86	4.08	12.69
Asset Turnover	0.47	0.34	0.29	0.31	-	-
Inventory Turnover	2.50	2.37	2.92	2.19	-	-
Quick Ratio	0.42	0.18	0.09	0.29	0.35	0.18
Current Ratio	1.17	0.48	0.38	0.89	0.52	0.33
Return on Equity (ROE)	-16.28%	-121.50%	-98.29%	-16.56%	-	-
Return on Assets (ROA)	-1.16%	-8.84%	-14.99%	-1.57%	-	-
Return on Capital (ROIC)	-1.35%	-11.37%	-19.12%	-1.98%	-	-
Earnings Yield	-7.55%	-21.19%	-	-	-	-
FCF Yield	-12.61%	-19.32%	-	-	-	-
Buyback Yield / Dilution	-24.72%	-20.88%	-11.78%	-8.34%	-14.88%	-
Total Shareholder Return	-24.72%	-20.88%	-11.78%	-8.34%	-14.88%	-

Source: S&P Capital IQ. Standard template. Financial Sources.